Imagine having a virtual copy of a patient's brain and heart that doctors can use to test treatments before actually performing them. This project creates a digital map of blood flow and clots to predict how a stroke will progress. It helps doctors pick the best surgery or medicine by simulating the outcome on a computer first.
Doctors currently rely on general protocols for stroke treatment, which may not fit every patient. This leads to suboptimal recovery and difficulty in predicting how a specific patient will respond to a thrombectomy or medication.
A suite of multi-scale digital twins including 3D fluid simulations of the left atria and models for cerebral blood flow and vessel wall remodelling.
If you are a device manufacturer dealing with high failure rates in thrombectomy tools — this project developed 3D models of thrombus fracture and constitutive models that provide a virtual testing ground to optimize device design.
If you are a software company dealing with generic treatment protocols — this project developed 5 personalized subject-specific digital twins that guide patient care and long-term management for stroke victims.
If you are a pharma company dealing with unpredictable drug responses in stroke patients — this project developed a 0D model of the coagulation cascade to predict thrombus formation and treatment outcomes.
Based on available project data, no specific pricing or cost structures are mentioned.
The project includes a multi-centre clinical trial to prove value, suggesting a path toward industrial-scale clinical adoption.
The project has an extensive valorisation strategy with adequate IP protection to ensure wide adaptation of the results.
The project period runs from 2023-12-01 to 2029-11-30, indicating a long-term development and validation cycle.
GEMINI implements a structured approach for data harmonisation and curation to ensure the models are interoperable.
The consortium is highly diversified with 22 partners across 12 countries, showing strong international validation. With a 27% industry ratio (6 companies, including 2 SMEs), there is a significant commercial focus compared to purely academic projects, balancing 13 universities and 2 research institutes.
Contact Stichting Amsterdam UMC in the Netherlands
Contact us to connect with the GEMINI consortium for licensing opportunities.
